Mirabegron + Placebo + Tamsulosin Hydrochloride
ApprovedCompleted 0 watching 0 views this week๐ฅ Hot
85
Development Stage
โ
Pre-clinicalโ
Phase 1โ
Phase 2โ
Phase 35
ApprovedIndication / Disease
Benign Prostatic Hyperplasia
Conditions
Benign Prostatic Hyperplasia, Overactive Bladder
Trial Timeline
Jun 13, 2016 โ Sep 11, 2018
NCT ID
NCT02757768About Mirabegron + Placebo + Tamsulosin Hydrochloride
Mirabegron + Placebo + Tamsulosin Hydrochloride is a approved stage product being developed by Astellas Pharma for Benign Prostatic Hyperplasia. The current trial status is completed. This product is registered under clinical trial identifier NCT02757768. Target conditions include Benign Prostatic Hyperplasia, Overactive Bladder.
Hype Score Breakdown
Clinical
30
Activity
20
Company
10
Novelty
10
Community
12
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT02757768 | Approved | Completed |
Competing Products
20 competing products in Benign Prostatic Hyperplasia